Med-tech firms raising money in public or private financings, including: Emboline, Establishment Lab Holdings, Lyra Therapeutics, MRI Interventions

Quarterly snapshots from biopharma companies with marketed products, including: Alexion, Biogen, Samsung Bioepis.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Albireo, Aprea, Astellas, F-star, Follicum, Merakris, Proqr, Pulmatrix, Vistagen.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaccine, Allergan, Aptinyx, BGI, Biocorrx, Cortexyme, Curetis, Dare, Evotec, Histogen, Inovio, Iteos, Theraly, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptevo, Autolus, Bayer, Eli Lilly, Exscientia, Incyte, Isofol, Kedrion, Miragen, Orion, Rubius, Sanofi, SQZ, Sumitomo Dainippon.

Biopharmas raising money in public or private financings, including: Albireo, Alector, Applied Genetic Technologies, Catabasis, DBV, Hemogenyx, Iox, Lyra, Portage, Seelos, Spero, Vizgen.

New hires and promotions in the biopharma industry, including: Insmed, Neoimmunetech, Oramed.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytosorbents

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bluestar Genomics, Polarean

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biodesix, Bright Machines, Current Health, Diagnostics for the Real World, Physiq, Sai Life Sciences, Sanuwave Health, Sequana Medical, Scorpio-V, Streck, Valdovations